UBS Lowers Oracle Price Target to $245
UBS analyst Karl Keirstead lowered the price target on Oracle (ORCL) to $245 (from $285) while maintaining a Buy rating on August 6, 2026.
“Oracle shares are -27% post its 4Q/May print, with investors shrugging-off strong revs growth results and guidance and focusing on several perceived risks – rising AI infra capex, uncertain/uninspiring ROIC, evidence of tightness in the credit markets for new large AI data center debt offerings, delays at a key site under construction in New Mexico and high customer concentration with OpenAI.
In this note we focus on each of these OCI-related concerns. Net, we conclude that material risk is already priced into the stock and that some risks (such as New Mexico delays) could be over-stated.
We remain Buy-rated.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
